Stock News

Eidelman Virant Capital Has Cut By $518,400 Its Telephone & Data Sys (TDS) Stake; 4 Analysts Bullish Antares Pharma, Inc. (ATRS)

Among 4 analysts covering Antares Pharma (NASDAQ:ATRS), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Antares Pharma had 11 analyst reports since March 9, 2016 according to SRatingsIntel. As per Wednesday, March 9, the company rating was maintained by Jefferies. The rating was maintained by Piper Jaffray with “Buy” on Tuesday, July 25. The firm has “Buy” rating by H.C. Wainwright given on Thursday, February 15. The company was maintained on Monday, August 7 by Jefferies. The firm has “Buy” rating given on Monday, October 23 by H.C. Wainwright. The rating was maintained by Jefferies on Tuesday, October 10 with “Buy”. The stock of Antares Pharma, Inc. (NASDAQ:ATRS) has “Buy” rating given on Friday, September 8 by H.C. Wainwright. The firm has “Buy” rating by Piper Jaffray given on Monday, October 23. The rating was maintained by H.C. Wainwright with “Buy” on Wednesday, November 8. The rating was initiated by H.C. Wainwright on Friday, June 23 with “Buy”. See Antares Pharma, Inc. (NASDAQ:ATRS) latest ratings:

15/02/2018 Broker: H.C. Wainwright Rating: Buy New Target: $3.5 Maintain
08/11/2017 Broker: H.C. Wainwright Rating: Buy New Target: $3.5 Maintain
23/10/2017 Broker: H.C. Wainwright Rating: Buy New Target: $3.5 Maintain
23/10/2017 Broker: Piper Jaffray Rating: Buy New Target: $3.0 Maintain
10/10/2017 Broker: Jefferies Rating: Buy New Target: $6.0 Maintain
08/09/2017 Broker: H.C. Wainwright Rating: Buy New Target: $5.0 Initiate

Eidelman Virant Capital decreased Telephone & Data Sys Inc (TDS) stake by 9.97% reported in 2017Q3 SEC filing. Eidelman Virant Capital sold 19,200 shares as Telephone & Data Sys Inc (TDS)’s stock declined 14.81%. The Eidelman Virant Capital holds 173,404 shares with $4.84M value, down from 192,604 last quarter. Telephone & Data Sys Inc now has $2.85B valuation. The stock increased 0.86% or $0.22 during the last trading session, reaching $25.68. About 956,095 shares traded or 59.17% up from the average. Telephone and Data Systems, Inc. (NYSE:TDS) has declined 0.51% since February 17, 2017 and is downtrending. It has underperformed by 17.21% the S&P500.

Analysts await Telephone and Data Systems, Inc. (NYSE:TDS) to report earnings on February, 23. They expect $-0.02 earnings per share, up 60.00% or $0.03 from last year’s $-0.05 per share. After $0.08 actual earnings per share reported by Telephone and Data Systems, Inc. for the previous quarter, Wall Street now forecasts -125.00% negative EPS growth.

Among 2 analysts covering Telephone and Data Systems (NYSE:TDS), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Telephone and Data Systems had 2 analyst reports since January 4, 2016 according to SRatingsIntel. The firm has “Mkt Perform” rating by Raymond James given on Monday, February 27. The firm earned “Neutral” rating on Monday, January 4 by JP Morgan.

Eidelman Virant Capital increased Pfizer Inc (NYSE:PFE) stake by 123,500 shares to 145,930 valued at $5.21 million in 2017Q3. It also upped Reading International Inc (NASDAQ:RDI) stake by 91,850 shares and now owns 377,650 shares. Drive Shack Inc (NYSE:LEN) was raised too.

Investors sentiment increased to 1.01 in Q3 2017. Its up 0.03, from 0.98 in 2017Q2. It increased, as 20 investors sold TDS shares while 73 reduced holdings. 33 funds opened positions while 61 raised stakes. 91.72 million shares or 1.42% more from 90.44 million shares in 2017Q2 were reported. Eidelman Virant has 173,404 shares for 2.87% of their portfolio. Acadian Asset Mngmt Ltd has 265,238 shares. Grp One Trading Ltd Partnership holds 300 shares. State Treasurer State Of Michigan invested in 0.01% or 34,536 shares. Glenmede Tru Na accumulated 0% or 2,365 shares. Aperio Grp Inc Ltd Liability holds 64,555 shares. Goldman Sachs Group stated it has 0% in Telephone and Data Systems, Inc. (NYSE:TDS). Capstone Invest Limited Com has invested 0.01% in Telephone and Data Systems, Inc. (NYSE:TDS). Baldwin Brothers Inc Ma holds 500 shares or 0% of its portfolio. First Quadrant Ltd Partnership Ca holds 0.24% or 440,773 shares in its portfolio. Renaissance Technology Ltd Liability Co holds 0.09% or 2.77M shares in its portfolio. Wellington Management Gp Limited Liability Partnership accumulated 305,736 shares. Legal General Public Limited Com reported 170,138 shares stake. Ajo Limited Partnership, Pennsylvania-based fund reported 2.96M shares. Perkins Coie Tru stated it has 0% in Telephone and Data Systems, Inc. (NYSE:TDS).

The stock increased 1.70% or $0.04 during the last trading session, reaching $2.39. About 3.18 million shares traded or 176.98% up from the average. Antares Pharma, Inc. (NASDAQ:ATRS) has risen 207.14% since February 17, 2017 and is uptrending. It has outperformed by 190.44% the S&P500.

Since October 3, 2017, it had 0 insider buys, and 2 selling transactions for $1.04 million activity. JACOB LEONARD S sold 230,000 shares worth $931,920. GARRITY THOMAS J also sold $105,000 worth of Antares Pharma, Inc. (NASDAQ:ATRS) shares.

Investors sentiment decreased to 1.29 in Q3 2017. Its down 0.78, from 2.07 in 2017Q2. It worsened, as 11 investors sold Antares Pharma, Inc. shares while 23 reduced holdings. 18 funds opened positions while 26 raised stakes. 53.56 million shares or 0.15% less from 53.64 million shares in 2017Q2 were reported. Geode Cap Ltd Liability Co stated it has 1.31 million shares. Wells Fargo And Com Mn owns 1.34M shares or 0% of their US portfolio. Ny State Common Retirement Fund reported 121,500 shares. Pennsylvania-based Janney Montgomery Scott Limited has invested 0% in Antares Pharma, Inc. (NASDAQ:ATRS). Jw Asset Mngmt Llc has invested 3.97% of its portfolio in Antares Pharma, Inc. (NASDAQ:ATRS). Lpl Limited Liability Com stated it has 46,194 shares. State Board Of Administration Of Florida Retirement Sys stated it has 59,413 shares. California Pub Employees Retirement reported 0% in Antares Pharma, Inc. (NASDAQ:ATRS). Commonwealth Equity Services has invested 0% in Antares Pharma, Inc. (NASDAQ:ATRS). Moreover, Citadel Limited Liability Corp has 0% invested in Antares Pharma, Inc. (NASDAQ:ATRS) for 114,848 shares. Ballentine Ltd Liability holds 100,000 shares. California State Teachers Retirement Sys holds 228,385 shares or 0% of its portfolio. Bnp Paribas Arbitrage, New York-based fund reported 14,469 shares. Renaissance Technology Ltd Limited Liability Company invested 0.01% in Antares Pharma, Inc. (NASDAQ:ATRS). The Nebraska-based Ameritas Prtnrs Incorporated has invested 0% in Antares Pharma, Inc. (NASDAQ:ATRS).

Antares Pharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company has market cap of $374.45 million. The companyÂ’s injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis and psoriasis patients to self-inject methotrexate at home; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache; ZOMA-Jet and Twin-Jector, a needle-free auto injector to deliver human growth hormone treatment to children without the use of a needle; and VIBEX disposable pressure-assisted auto injectors. It currently has negative earnings. In addition, the firm is developing VIBEX auto injectors for treating anaphylaxis; disposable pen injectors for diabetes and osteoporosis; Makena QuickShot auto injectors for reducing risk of preterm birth; and VIBEX QS Testosterone for testosterone replacement therapy for men who have testosterone deficiency.

Leave a Reply

Your email address will not be published. Required fields are marked *